Hierarchy and molecular properties of house dust mite allergens  by Thomas, Wayne R.
lable at ScienceDirect
Allergology International 64 (2015) 304e311Contents lists avaiAllergology International
journal homepage: http : / /www.elsevier .com/locate/al i tInvited review articleHierarchy and molecular properties of house dust mite allergens
Wayne R. Thomas*
University of Western Australia, Telethon Kids Institute, Western Australia, Australiaa r t i c l e i n f o
Article history:
Received 26 April 2015
Received in revised form
5 May 2015
Accepted 7 May 2015
Available online 13 June 2015
Keywords:
Allergens
Allergy
Blomia
Dermatophagoides
House dust mite
Abbreviations:
CD, circular dichroism; nDer, preﬁx for
natural Dermatophagoides allergen;
rDer, preﬁx for recombinant
Dermatophagoides allergen; ELISA, enzyme
linked immunosorbent assay; HDM, house
dust mitel; MD-2, Myeloid differentiation
antigen 2; ML-domain, MD-2-like domain;
LPS, lipopolysaccharide; TLR4, toll-like
receptor 4* University of Western Australia Centre for Child H
Institute, 100 Roberts Road, Subiaco, Western Austral
E-mail address: Wayne.Thomas@telethonkids.org.
Peer review under responsibility of Japanese Soci
http://dx.doi.org/10.1016/j.alit.2015.05.004
1323-8930/Copyright © 2015, Japanese Society of Alle
licenses/by-nc-nd/4.0/).a b s t r a c t
The allergenic load of house dust mite allergy is largely constituted by a few proteins with a hierarchical
pattern of allergenicity. The serodominant speciﬁcities are the group 1&2 and the group 23 faecal al-
lergens. The collective IgE binding to the group 1&2 allergens can measure unequivocal HDM sensiti-
sation better than HDM extracts although discrepancies have been found in regions with complex
acarofauna suggesting a need to investigate the speciﬁcity with allergen components. The group 4, 5,
7&21 allergens that each induce responses in about 40% of subjects are mid-tier allergens accounting for
most of the remaining IgE binding. Their titres are proportional to the concomitant responses to Der
p1&2. Group 2 allergen variants have different antibody binding. Body proteins only occasionally induce
sensitisation although a higher prevalence of binding by atopic dermatitis patients provides a new
avenue of research. A broad spectrum of IgE binding has been associated with diverse symptoms but not
with the severity of asthma which is associated with low IgG antibody. Some allergens such as the group
14 large lipid binding proteins and the recently described proteins Der f 24e33, need further investi-
gation but with the cognoscence that other denominated allergens have been found to be minor sen-
sitisers by comparative quantitative analyses. Scabies is a confounder for diagnosis with extracts,
inducing cross-reactive antibodies with Der p 4&20 as is seafood allergy with cross reactivity to Der p 10
a minor HDM allergen. The HDM genome sequence can now be used to verify allelic and paralogous
variations.
Copyright © 2015, Japanese Society of Allergology. Production and hosting by Elsevier B.V. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
The dominant house dust mite (HDM) allergen Der p 1 is found
at concentrations of 0.05e0.2 ng/m3 in inhalable indoor air, mostly
on large particles, and contrary to dogma the lowest exposure is
found in bed.1 Pollen and cat allergens are found at the higher levels
of 1e5 ng/m3 and 20 ng/m3 respectively.2 Most HDM allergy can be
accounted for by responses to a small number of proteins. The
immunodominant group 1&2 allergens are both about the 40th
most abundant proteins produced by HDM3 and the recently
recognized potent sensitiser Der p 234 has only been found in
minute quantities, although in faeces. Each of the HDM allergen
components has a characteristic propensity to induce sensitisation
providing a resource for investigating the events underpinning
sensitisation. Knowledge from this can assist in the development ofealth Research, Telethon Kids
ia 6008, Australia.
au.
ety of Allergology.
rgology. Production and hosting by Elsenew types of immunotherapy, improved diagnoses, standardised
measurements and the identiﬁcation of confounding cross-
reactions.
Spectrum of HDM allergens
Initial electrophoretic analyses of HDM extracts indicated a
complex pattern of IgE binding. These assays however accentuate
low titre antibody binding as well as disregarding the variable
concentrations of components, the presence of degradation prod-
ucts and variations in glycosylation. Since IgE responses to one
allergen can promote responses to bystander antigens, collateral
responses to otherwise non-allergic components would be ex-
pected imposing a need for quantitation to identify the main al-
lergens that drive sensitisation. Absolute (gravimetric) and
comparative titrations are thus required. The term serodominant
has been used here to refer to allergens that quantitatively make
the most important contribution to the IgE responses in contrast to
the term major used by the IUIS allergen nomenclature that only
refers to prevalence.vier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/
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pteronyssinus where Der p 1&2 have long been recognized as
serodominant speciﬁcities. Trombone et al.5 showed that 95% of
subjects with greater than 2 IU/mL of anti-HDM IgE bound one and
usually both of these speciﬁcities with the combined titres closely
correlating with anti-HDM titres and accounting for 60% of anti-
bodies. Following studies showing that absorption of sera with
nDer p 1 and rDer p 2, 5, 7, 8&10 removed amedian of 80% of the IgE
binding of sera to HDM, and the binding to their natural counter-
parts,6 a quantitative study was conducted with this panel
expanded to include nDer p 3 and 4 and enzymatically active rDer p
20.7 Der p 1&2 accounted for 50e65% of the antibodies of each
subject and although only recognized by 40% of subjects each of Der
p 4, 5 and 7 accounted for 10e15% of the total bindingwhen present
and collectively most of the non-Der 1&2 binding. The titres to Der
p 4, 5&7 in different subjects strongly correlated with their titres to
Der p1&2. IgE binding to Der p 3 only accounted for about 2% of
antibody with few subjects producing more than a 1e2 IU/mL.
Binding to Der p 8, 10 and 20 was infrequent only occasionally
reaching signiﬁcant titres. The IgG binding for each allergen
mirrored the IgE binding although the correlation of IgE and IgG for
individuals was poor. Titres obtained with a larger 13-member
panel showed much the same pattern for Singaporean children.8
It provided additional data showing mid-tier responses for Der p
21, low responses to Der p 13&15 and sporadic responses to pep-
tides representing Der p 14. Titres to rDer p 4 were low but since it
was produced in Escherichia coli this would be expected from its
poor folding in other studies. Similar binding prevalences for Der p
1, 2, 4, 5, 7, 8,10 and a Der p 14 peptidewere found for subjects from
several European countries.9
IgE binding to the group 11 paramyosin allergens has been
difﬁcult to appraise because of the instability of the recombinant
and natural proteins and the lack of speciﬁcity controls and quan-
titation. A recent study of structurally-validated paramyosin found
that it bound IgE in 5% of sera from patients with asthma but 60%
subjects with atopic dermatitis.10 The same study showed that the
prevalence of IgE antibodies to Der p 10, 14&18 was also higher
although titres were low.
Der p 23, found in the chitinous membrane of the mite faecal
ball, has been discovered to bind IgE with titres similar to Der p 1&2
and have high activity in basophil degranulation tests.4 The titres
showed a strong concordance with binding to Der p 1&2 although
some subjects had high IgE binding to Der p 23 without binding to
Der p 1 or 2.
The IgE binding to serine proteases is an issue because histori-
cally some studies have indicated prevalent binding for group 3
trypsin allergens but comparisons with gravimetric estimations
have found low titres titres to group 37,8,10,11 allergens and lower
titres to the group 6 chymotrypsin.10 Reponses to the collagenolytic
group 9 serine protease were even lower.12 Recently similar low
binding was reported for natural and functional rDer p 3 but a non-
catalytic mutant showed higher binding for some sera providing a
valuable reagent for further study.13Table 1
Serodominant allergens.
Group Biochemical IgE bindingy Biological
1 Cysteine protease 80e100%
25e200 IU/mL
Proteolysis
2 ML domain protein 80e100%
25e200 IU/mL
Lipid bind
23 Peritrophin 74%
Similar to Der p 1&2 by ISAC array
Chitin bind
y Numbers illustrative.The Der f 1514&1815 allergens were discovered as important al-
lergens of HDM-allergic dogs having primary structures similar to
chitinase enzymes. It is however now known that the highly
reactive and heavily glycosylated Der f 15 bound dog IgE via car-
bohydrate determinants16 and that the IgE binding by humans
found in 40% of allergic subjects is usually of low titre.17
Pyroglyphid house dust mite homologues of the Blomia tropi-
calis chitin-domain containing peptide Blo t 12 and the anti-mi-
crobial peptide Blo t 19 have not been found and will not be
considered here.
Serodominant allergens (groups 1, 2 and 23) (Table 1)
Group 1 allergens
X-ray crystallography of rDer p 118 and nDer f 119 has shown the
expected cysteine protease structures and Der p 1 and Der f 1,
which have 81% sequence identity, show subtle differences in the
contact residues for binding cross-reactive monoclonal antibodies.
Der p 1 cDNA from different environments and pharmaceutical
cultures show sporadic amino acid changes throughout their se-
quences with most cDNAs differing from each other by 1e3 resi-
dues.20,21 Only one substitution, position 124 valine/alanine.
showed a regular allelic exchange and this has importance for T-cell
responses of mice22 and some humans.20 Der p 1.0102 and Der p
1.0105 could be used for recombinant allergens to accommodate
these substitutions noting that the histidine-50 of the ﬁrst-cloned
Der p 1.0101 is rare. Der f 1 in contrast showed little variation21
as also found with genomic DNA from Pakistan23 and some
commercially cultured mites. A smaller similarly-obtained sample
ofD. pteronyssinus corroborated the exchanges found in Der p 1. The
sporadic changes might only be signiﬁcant in special circumstances
but it should be noted that error rates from reverse transcription
and PCR do not account for their frequency and they are not found
in parallel analyses of group 2 allergens. A different level of conﬁ-
dence should be placed in other results without this discrimination
but they did ﬁnd common substitutions.24
Group 2 allergens
The structure solved for Der p 225 and Der f 226,27 deﬁned theML
(MD-2 like lipid binding) domain proteins. It consists of a raft of
beta sheets folded over like a clam to form an internal lipid-binding
cavity leaving two clusters of connecting loops opposed to each
other. The binding of an unknown lipid in the cavity of recombinant
allergens has been demonstrated and from NMR the clam appears
ﬂexible being able to accommodate different ligands. Der f 2 can
bind lipopolysaccharide (LPS) at high afﬁnity with structural
changes similar to those occurring for its MD-2 homologue.28
Allelic variants of Der p 220,21,24,29 and Der f 221,24,30 show a
pattern indicating different genetic lineages that might be impor-
tant for allergy. For D. pteronyssinus the amino acids 40, 47, 111 and
114 VTMD (in single letter amino acid notation) in Der p 2.0101 canactivity Location in mite Molecular weight
Faecal 25 000
ing including LPS Faecal 14 000
ing to stabilise dung ball (proposed) Faecal 8000
W.R. Thomas / Allergology International 64 (2015) 304e311306be substituted with varying penetrance to LSLN respectively with
Der p 2.0104 having all four substitutions. Der f 2 shows sub-
stitutions in residues 57, 58, 59 and 75, from SLDF in Der f 2.0101 to
NINVY in Der f 2.0116, although there are substitutions in residues
88, 111 and 125 common to both divisions. The variants show a
different geographical distribution with for Dermatophagoides far-
inae, Der f 2.0101-like sequences predominating in Korea24 and
probably Japan24 and Der f 2.0116-like sequences predominating in
Europe. Both types of Der f 2 have been reported in sequences from
China with the Der f 2.0116-like sequence from Hainan and
Guangzhou and Der f 2.0101-like sequences from elsewhere.30 For
D. pteronyssinus the Der p 2.0101 clones that predominate in Perth,
Australia20,29 have not been detected in Thailand21 and constitute
50% of the sequences in Korea.31
The substitutions of Der p 2 and Der f 2 are in different regions of
the molecule so the divergent patterns might only be from founder
effects. The Der p 2 substitutions however cluster together in a loop
region affecting monoclonal antibody32 and IgE binding. Der p
2.0104 binds IgE on average at twice the titre of Der p 2.010130,33
including in Australia where it appears less abundant. Addition-
ally Der p 2.0101 and Der p 2.0104 could inhibit IgE binding to Der p
2.0104 by sera from Australia but higher concentrations of Der p
2.0101 were required for sera from Thailand.34 Although the lack of
an effect of variants on basophil degranulation has been reported35
this is not surprising for subjects with high antibody titres but
immunotherapy based on IgG blocking antibodies would need to
consider variants because, as shown in mice, they can induce an-
tibodies with poor binding to other variants.34 A caveat of these
ﬁndings is that natural variants have yet to be examined.
Group 23 allergens
The peritrophin-like Der p 23 is part of the chitinous peritrophic
membrane of the dung ball4 thought to control digestion and pro-
tect the gut from digestive processes. It was found in low amounts in
HDM extracts questioning its effects on diagnosis and showing the
need to determine the amount in inhaled air. Given that it induces
high IgE titres and it must induce substantial Th2 responses and
hence at least pathological changes via cytokines such as IL-13 as
found for subjects with high expression of periostin.36
Mid-tier allergens (groups 4, 5, 7, 21) (Table 2)
Group 4 allergens
Group 4 allergens are alpha amylases found in faeces.37 They
have high sequence conservation that could cause confounding
cross reactivities. D. pteronyssinus has 86% identity with D. farinae
and 65% with storage mites compared to a 30e40% for most other
allergens. The identity is 50%with insect andmammalian amylases.
High IgE binding has been found in indigenous Australians in theTable 2
Mid tier allergens.
Group Biochemical denomination IgE bindingy Biological acti
4 Amylase 40%
5e50 IU/mL
glycoside hydr
5 Unknown 30e40%
5e50 IU/mL
Hydrophobic b
proposed from
7 Similar to LPS-binding protein/
bactericidal permeability
increasing family
40%
5e50 IU/mL
Hydrophobic b
proposed
21 Unknown group 5 homologue
(paralogue)
30%
5e100 IU.mL
Hydrophobic b
proposed
y Numbers illustrative.absence of antibody to Der p 1&238 and to Blo t 4 in China39 in the
absence of antibodies to the serodominant Blo t 5 allergen of Blomia
tropicalis. In Australia there is evidence for high cross-reactions
from present and past scabies infections.40
Groups 5&21 allergens
The group 5&21 allergens are homologous proteins unique to
mites without known function. Der p 5&21 only have 26% sequence
identity while Blo t 5 &21 from B. tropicalis not only have over 40%
sequence identity with each other but also with both Der p 5&21.
There do not appear to be any motifs that differentiate group 5 and
21 sequences. There is only a low degree of cross reactivity between
Der p 5 and 2141 and between Der p 5 and Blo t 542 but Blo t 21 and
Der p 21 cross react.43 The structure of Der p 5 shows a monomeric
bundle of coiled coils that can polymerise to create a 6-member cage
with a hydrophobic cavity44 It agrees with that solved by NMR for
Blo t 545 and with minor differences with that of Chan et al.46 and
they closely resemble the structure of Blo t 21.43 The group 5&21
allergens are the serodominant allergens of B. tropicalis.8
Group 7 allergens
The group 7 structures show these uniquely Arachnida proteins
to be members of the LPS-binding/bactericidal permeability
inducing proteins47,48 with similarities to insect odorant binding
proteins that include hormone receptors.49 They have elongated
structures with antiparallel beta-sheets wrapped around a helix to
create a lipid-binding domain. Der p 7 and Der f 7 seem not to bind
LPS but weakly bind the fungal lipopeptide polymyxin B. The nat-
ural group 7 allergens can be highly glycosylated (30%) and there
are at least 3 different glycosylation isoforms found in varying
degrees in different HDM extracts.50
Minor allergens (groups 3, 6, 8, 9, 10, 11, 13, 15, 16, 17, 18, 20)
(Table 3)
Group 3, 6 &9 allergens
The group 3, 6 &9 allergens are the serine proteases trypsin,
chymotrypsin and a collagenolytic enzyme respectively. Der p 3 has
been reported to be low in body extracts but it is abundant and
stable in spent mite media and Der f 3 has been demonstrated in
faeces.51
Group 8 allergens
Although they have low IgE binding the group 8 glutathione-S-
transferases of D. pteronyssinus7,8,52 and B. tropicalis7 could have
importance because of their demonstrated cross reactivity with
cockroach allergens52 however only 6% of HDM-allergic subjects invity Location in mite Molecular weight
olase Faecal 56 000
inding
structure
Faecal 14 000 subunits form
hexameric bundle
inding Unknown Polypeptide 21 000 with
glycovariants of 24&29 000
inding Gut 14 000 subunits form hexameric bundle
Table 4
Allergens of unknown importance.
Group Biochemical denomination
14 Large lipid transfer protein
22 MD-2 like protein
24 Ubiquinol-cytochrome c reductase binding protein
25 Triosephosphate isomerase
26 Myosin alkali light chain
27 Serpin
28 Heat Shock Protein
29 Cyclophilin
30 Ferritin
31 Coﬁlin
32 Pyrophosphatase
33 Alpha-tubulin
Table 3
Minor allergens.
Group Biochemical denomination Biological activity (predicted)
3 Trypsin Serine protease
6 Chymotrypsin Serine protease
8 Glutathione-S -transferase Glutathione transferase
9 Collagenolytic protease Serine protease
10 Tropomyosin Muscle protein
11 Paramyosin Muscle protein
13 Fatty acid binding protein Lipid transfer
15 Chitinase Family 18 of glycosyl hydrolases
16 Gelsolin lipid-binding Microtubule regulator
17 EF hand protein Undetermined
18 Chitin binding Non-catalytic chitinase-like
20 Arginine kinase ATP maintenance
W.R. Thomas / Allergology International 64 (2015) 304e311 307Korea,53 where cockroach allergy is prevalent, had anti-Der f 8
antibodies.
Group 10 allergens
The group 10 tropomyosins were ﬁrst reported as prevalent
high-titre IgE binding proteins in Japan54 but recent analysis with a
quantitative assay revealed little IgE binding with sera from pa-
tients in the same prefecture55 in agreement with the low binding
found in Australia,7 Europe,56 and Korea.53 Tropomyosins are
famous for their conserved amino acid sequences with HDM
tropomyosins being 75% identical to other arthropod tropomyosins
and thus being implicated in cross reactivity. While it does occur
with shrimp57,58 and cockroach59 the signiﬁcance has been over-
estimated. There is only low-level sensitisation to both cockroach59
and HDM tropomyosin and subjects with both HDM and shrimp
allergy do not necessarily have IgE antibody binding to Der p 10
even when they bind shrimp tropomyosin. More interestingly the
15% of HDM-allergic subjects responding to tropomyosin had
higher levels of total IgE and IgE antibodies to a diverse spectrum of
HDM allergens.56 They did not however have more clinical symp-
toms and IgE to Der p 10 was not only found in low titres but was a
poor elicitor of basophil degranulation.
Group 11 allergens
Paramyosins that constitute the group 11 allergens are compo-
nents of muscles but can be found in the teguments of helminthic
parasites where they are often prominent antigens. They are less
conserved than tropomyosinwith Der p 11 showing 95% identity to
B. tropicalis and scabies but only 60% to insects and 50% to helminth
proteins. The speciﬁcity of published IgE assays with degraded
proteins is questionable especially since one of them showed far
stronger IgE binding signals to Der p 11 than those to Der p 2.60
Recently Banajee et al. noted degradation and aggregation in nat-
ural and recombinant Der p 11 preparations but with CD spectra
showing the expected secondary structure.61 Sera of subjects with
respiratory HDM allergy examined with this preparation only
showed 6% IgE binding prevalence but it was 60% for atopic
dermatitis patients.
Group 13 allergens
The group 13 allergens are fatty acid binding proteins that
transport fatty acids and other lipids such as eicosanoids and reti-
noids. Recombinant Der f 13 has the expected structure and its
binding to fatty acid and other lipid ligands has been demon-
strated.62 They however only occasionally bind IgE despite being
one of the most abundant HDM proteins.3Group 15&18 allergens
rDer p 15 and rDer p 18 representing a chitinase and a chitinase-
like chitin-binding protein can be produced in Pichia pastoris with
structures resembling the natural proteins17 but are weakly aller-
genic. A key point is that Der f 15 was discovered as the dominant
allergen for HDM-allergic dogs but it is now known that the IgE
binding was entirely directed to its large carbohydrate moiety
either from N- or O-glycosylation.16 An intriguing aspect of the
responses to Der p 15&18 is despite the disparate sequences (24%)
and lack of cross reactivity their titres in individuals correlate
highly but not to titres to Der p1, 2, 5&7.17
Group 16&17 allergens
The group 16&17 allergens correspond to little-investigated
gelsolin and EF-hand proteins of D. farinae, allergens reported to
show weak binding IgE in 50% and a small percentage of allergic
subjects respectively.63
Group 20 allergens
Themothmealworm arginine kinase allergenwas found to bind
IgE in the sera of HDM-allergic subjects64 consistent with their 75
and 80% identity to insect and crustaceans homologues. They are
abundant proteins similar to creatine kinase of mammals that
generate energy in muscles. Despite being a minor HDM allergen7,8
Der p 20 exhibits high binding to IgE and IgG from the sera of
people with active scabies.40
Allergens of unknown importance (groups 14, 22, 24e33)
(Table 4)
Group 14 allergens
The group 14 allergens were ﬁrst represented by two cDNA
clones that encoded residues 1310e1650 (Mag 1) and 891e1239
(Mag-3) of Der f 14. The peptides that are not natural products
bound IgE in 30 and 70% of sera from allergic subjects. Antibodies
produced against Mag-3 showed it to be part of a 170 000 MW
protein that degraded in extracts to many IgE-binding products.65
Complete cDNA66 showed it was constituted by 1650 amino acids
of MW 189370 with 90% identity between pyroglyphid mites and
43% with B. tropicalis, homologous to the large lipid transfer protein
(LLTP) family that includes vitellogenins of eggs and type I and II
apoliphorins that transport retinoids and other lipids. Antibodies
produced against Der p 14 reacted with mite eggs and male and
female bodies indicating a protein or proteins with both func-
tions.67 Although full-length proteins have been reported for
W.R. Thomas / Allergology International 64 (2015) 304e311308homologues of other species, HDM studies have only been con-
ducted with peptides. IgE-binding to peptide 1e260 representing
the N-terminal domainwas infrequent9 while binding with peptide
1310e1650 in Australia at a median of 7 IU/mL suggested potential
importance68 as has binding to peptide 891e1239 in Singapore.8 It
was also shown that the equivalent peptide of scabies bound IgE at
10 fold higher levels for scabies infested but not HDM-allergic
subjects.68 A recent European study found that Der p 14 rarely
bound IgE in the sera of asthmatics but bound IgE in 67% of atopic
dermatitis patients although at low titre.61 Vitellogenin-like aller-
gens have now been reported in bee venom69 and they the major
allergens for people allergic to ﬁsh roe.70
Group 22 allergens
Der f 22 was recorded by the IUIS nomenclature subcommittee
following the submission of sequence and allergenicity informa-
tion. It is an ML-domain protein similar to the group 2 allergens but
only has 42% amino acid identity. Its allergenicity has not been
published but it is in the D. farinae genome.71
Group 24 allergens
rDer f 24, a ubiquinol-cytochrome c reductase binding protein
(UQCRB)-like protein, has been reported to produce skin test re-
actions in 50% of HDM allergic subjects and by ELISA to bind IgE in
sera from 18/18 patients.71 The IgE responses have yet to be
quantitated or compared with other allergens.
Newly denominated allergens
2-D immunoblotting has revealed IgE binding by Der f 25 (tri-
osephosphate isomerase), Der f 26 (myosin alkali light chain), Der f
27 (serpin), Der f 28 (heat shock protein), Der f 29 (cyclophilin), Der
f 30 (ferritin) Der f 31 (coﬁlin), Der f 32 (pyrophosphatase) and Der f
33 (alpha-tubulin).72 Allergenicity was further examined with
chromatographically isolated proteins although the proﬁles show a
requirement for further puriﬁcation and then quantitation and the
exclusion of cross-reactive carbohydrate binding. Little IgE binding
to myosin alkali light-chain protein, pyrophosphatase and ferritin
has been found to recombinant proteins71,73 in other studies and
ferritin has been found not to induce Th2-biased cytokine
responses.73
Biological activity and allergenicity
It has been speculated that biological effects of allergens on
barrier and homeostatic functions and their interactions with
pathogen and danger associated molecular patterns are important
determinants of allergenicity.74 Knowledge of this could have
considerable application for the development of pharmaceutical
interventions and the development of mouse models with some
semblance to the pathophysiology of HDM sensitisation.
The cysteine protease group 1 allergens hydrolyse enumerable
proteins that might affect allergic responses75 and the E64 catalytic
inhibitor has been reported to reduce their sensitising ability in
alum-adjuvanted mouse models.76,77 Investigations conducted
with the homologue papain have shown that it induces chronic
Th2-type inhalation allergy in mice without adjuvant and stimu-
lates responses to bystander antigens in an E64 inhibitable
manner.78,79 There are however concerns about the biological sig-
niﬁcance since IL-33 release, shown to occur in papain sensitisa-
tion,80 from damaged cells activates type 2 innate lymphoid cells to
unleash their Th2 promoting activity. As documented elsewhere2
cysteine proteases are highly susceptible to oxidative inactivation,and no activity of cysteine proteases has been demonstrable in
HDM extracts without adding reducing agents that would not be
encountered in the oxidising extracellular environment.2
Cysteine proteases are rarely allergens. Their enzymatic activity
can be readily demonstrated in extracts of storage mites81 that
preferentially respond to other allergens including Lepidoglyphus
destructor,82 Glycyphagus domesticus83 and Chortoglyphus arcua-
tus.84 Whenmeasured in calibrated comparative assays Blo t 1 from
B. tropicalis, in contrast to early assays, shows little IgE binding
compared with Blo t 5&21, the serodominant allergens.9 While the
cysteine protease activities described in cultures of Lepidoglyphus
destructor, Glycyphagus domesticus were half those of Dermato-
phagoides spp. and 15% for B. tropicalis, these depend on the nu-
trients and the stage of culture and Der p 1 levels in homes of
sensitised subjects vary over this range.85 Monoclonal antibody
detection reported Blo t 1 to be 0.5 mg/mg of protein in B. tropicalis
extracts close to the 1e3% reported for Der p 1.86
Cysteine proteases are abundant in the cell wall of birch and
ragweed pollen but only induce IgE antibody in a small percentage
of the most allergic subjects87 although a cysteine protease from a
more extractable fraction of ragweed pollen showed allerge-
nicity.88 It bound IgE from 60% of allergic subjects and induced
basophil activation but to a lesser extent than Amb a 1.88 Quan-
titative IgE binding and T-cell studies will provide interesting data
to compare with the well established the immunodominant
allergen. The most commonly encountered non-mite cysteine
protease allergen is actinidin, Act d 1, from kiwifruit that com-
prises 50% of the protein in the fruit pulp. The presence of IgE
antibody to Act d 1 in kiwifruit allergic subjects varies
geographically from 11% in Western and Central Europe, 32% in
Iceland89 and reported as unimportant in England.90 The most
prevalent kiwifruit allergens are the pollen related PR-10 and
proﬁlin proteins and although IgE to Act d 1 is more prevalent in
subjects without pollen allergy it was only found in 40% of this
subgroup.89
Experiments in mice showing that Der p 2 might functionally
mimic MD-2 by binding LPS and then loading it and itself onto
TLR-4 suggested a mechanism that could enhance its allerge-
nicity91 and indeed Der f 2 was shown to bind LPS with high af-
ﬁnity in similar manner to MD-2.28 The transient sensitisation
shown in MD-2 deﬁcient mice has however not been shown to be
able to be sustained and no evidence for humans has been re-
ported. It is not known if LPS could displace the natural group 2
ligand and how MD-2-like binding would help the responses of
subjects already replete in MD-2. Indeed epicutaneous non-
adjuvanted Der p 2 can induce prolonged Th2 responses by TLR4
independent mechanisms.92 The same study also showed that LPS
binding might have an important function of protecting Der p 2
from protease.
The potency of Der p 23 suggests a delivery system that could
include chitin-mediated adjuvant activity. Chitin can interact with
the TLR-2 and Dectin 1 innate immune receptors93 as well as
mammalian chitotriosidase94 that in pulmonary cryptococcal
infection can cleave inﬂammatory products from chitin to initiate
harmful Th2 responses. The ability of chitin binding to enhance Th2
responses has been demonstrated in mice showing chitin increased
Th2 responses to the chitin-binding-domain peptide Blo t 12.95
Although they are minor allergens, the concordance of the IgE ti-
tres to the chitinase-like Der p 15&18 and their discordance with
other allergens17 indicates that they are regulated differently,
perhaps via a chitin pathway.
The structures of the group 5, 7&21 allergens suggest that they
have structures and that can bind lipid, glycoprotein and glycolipids
to interact with the innate immune system and affect antigen
delivery2,96
W.R. Thomas / Allergology International 64 (2015) 304e311 309Component resolved diagnosis
The proprietary ImmunoCAP ISAC array contains the natural
group 1 and recombinant group 2 allergens of D. farinae and
D. pteronyssinus, and rDer p 10. It also contains potential cross-
reacting tropomyosins, glutathione-S- transferase and arginine ki-
nase proteins from other species.
Results with these reagents showed an almost excellent
concordance of the sum of the IgE anti-Der p1&2 titres and those to
HDM extract in 55 Japanese subjects.55 The two subjects who failed
to bind Der p 1 or 2 had anti-HDM titres of 1e2 IU/mL, levels not
usually associated with sensitisation. Similar results, 94%, were
found in France97 and with custom reagents 96% in Australia with
titres of non-Der p 1&2 allergens exceeding 3.5 IU/mL in only 0.05%.
Results from Sao Paulo Brasil however showed lesser, 83%, binding
to a combination of Der p1&2 but this was 95% with a cut-off of
2 IU/mL for the HDM titre.5 The lesser concordance might result
from the high degree of cockroach and B. tropicalis sensitisation in
Sao Paulo, for example cross-reactivity with Blo t 21.48 Similarly
Singapore where only 78% of subjects had IgE binding to a combi-
nation of Der p 1&28 has a high prevalent sensitisation to
B. tropicalis.
Although binding to Der p 10 alone has been described56 it was
not found in subjects that did not bind Der p 1&2 binding in studies
in Japan55 or Australia7 where, for Australia, Der p 4 with contri-
butions from Der p 5&7 could be implicated. The combined Der
p1&2 titres can provide superior precision by using known and
repeatable concentrations of the reactants without confounding
cross reactivity and moreover they have been shown to correlate
best with bronchial responsiveness to HDM.55 The use of serodo-
minant allergen components is not necessarily a compromise from
the current practice since many proprietary extracts often contain
undetectable levels of the other important allergens.98 Additionally
since 20e30% of subjects have discordant titres to Der p 1&2,8,27,55
the use of extracts with 6-fold variations in these components98 can
produce variable measurements. Adding the group 23 allergens
would provide a third serodominant allergen and a useful change
would be to include the high-IgE binding Der p 2.0104 variant.
Consideration of Der f 2 variants might also be important.
Scabies is already a known major confounder because scabies-
infected or exposed subjects have high-titre IgE binding to Der p
4 (amylase) and arginine kinase (Der p 20) with the anti-Der p 4
persisting in previously exposed subjects. In the tropics of
Australia40 this has likely resulted in themisclassiﬁcation in genetic
and epidemiological studies of respiratory disease in indigenous
subjects.38 The use of component resolved diagnosis would clearly
recognise the lack of Der p1&2 antibodies and the high titres to Der
p 4&20. This is likely to impact on the usefulness of HDM allergen
extract testing in many countries such as Fiji where the prevalence
of scabies infection is 20%.99 A large impact of scabies will be in
developing regions where changes in lifestyle are resulting in
increased incidences of atopic disease necessitating monitoring to
predict health service needs. However, taking the United Kingdom
as an example, where the population prevalence of scabies is
0.27%100 therewill be a signiﬁcant number of incorrect diagnoses in
most regions.
It has been reported that subjects with IgE antibodies to a large
spectrum of allergens are the most likely to have nasal and skin as
well as respiratory symptoms8,101,102 but this does not apply to the
severity of respiratory disease as observed in Europe,56,103 and
Australia.7,11 where children recruited from a hospital emergency
department had the same pattern of allergen recognition as stable
asthmatics included those with persistent and recurrent asthma.
The large difference found was the paucity of IgG antibody in the
severe groups.7,11 The recent demonstration that HDM-allergicatopic dermatitis patients have a high prevalence of IgE anti-
bodies to the body components Der p 10, 11&14 not found in sub-
jects with respiratory disease61 suggests this might be prognostic
for the persistence of eczema from childhood.
Conclusions
The probability of developing disease after HDM sensitisation is
proportional to the degree of sensitisation measured by IgE anti-
body titre.104 It progresses from 30% at a titre of 3 IU/mL to 60% at
the highest titres. From another perspective the IgE antibody titres
of subjects diagnosed with allergic disease by clinical criteria, by
specialist allergists, are above 3.5 IU/mL.105 It is now apparent that
this is mostly binding to a small deﬁned group of HDM
components.
From studies of D. pteronyssinus 50e70% of IgE binding of ex-
tracts is due binding to Der p1, 2 & 23 that collectively induce re-
sponses in nearly all HDM allergic subjects and most of the rest is
constituted by IgE to one or all of the mid-tier allergens Der p 4, 5,
7&21. The ﬁnding with Der p 23 should be corroborated as a pri-
ority. Binding to the serodominant and mid-tier HDM components
follow a typical pattern with the size of the responses to the mid
tier allergens being, when present, proportional to the responses to
serodominant allergens. This pattern has also been found in chil-
dren with severe disease with the difference in their responses
being a paucity of IgG.
Given the dominance of Der p 1&2 in HDM extracts, and lack of
mid-tier and cross reactive allergens in a great many of them, the
use of components would be sufﬁcient to determine unequivocal
allergic sensitisation and to indicate potential cross reactions. In
line with evidence unravelling in tropical Australia cross-reactive
anti-scabies antibodies contraindicate the use HDM extracts in
many environments where allergic disease might be expected to
increase hand-in-hand with the increased sanitation of living
conditions. IgE binding to Der p 4&20 and the absence of binding to
Der p 1&2 can identify this. Consideration of using the most reac-
tive group 2 variants should be made and this could be more
important for the efﬁcacy of immunotherapy.
The allergenicity of group 14&22 and recently denominated
allergens need further investigations that use pure allergens,
eliminate carbohydrate binding and ascertain absolute IgE binding
titres. Many denominated allergens have not met expectations
when examined under such conditions as elaborated elsewhere.106
The availability of HDM genome will also provide information and
it is noted that the group 2-like Der f 22 gene has been identiﬁed.
The recent discovery that subjects with atopic dermatitis have a
higher prevalence of IgE responses to the body but not the faecal
allergens of HDM provides a new avenue of research for this
disease.
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